| Year |
Citation |
Score |
| 1980 |
Stoeckel K, McNamara PJ, McLean AJ, duSouich P, Lalka D, Gibaldi M. Nonlinear pharmacokinetics of indocyanine green in the rabbit and rat Journal of Pharmacokinetics and Biopharmaceutics. 8: 483-496. PMID 7252792 DOI: 10.1007/Bf01059547 |
0.324 |
|
| 1979 |
Crow JW, Gibaldi M, Levy G. Comparative Pharmacokinetics of Coumarin Anticoagulants XLII: Effect of Phenobarbital on Systemic availability of Orally Administered Dicumarol in Rats with Ligated Bile Ducts Journal of Pharmaceutical Sciences. 68: 1309-1312. PMID 92562 DOI: 10.1002/Jps.2600681030 |
0.368 |
|
| 1979 |
Crow JW, Gibaldi M, Levy G. Comparative Pharmacokinetics of Coumarin Anticoagulants XLIL: Effect of Phenobarbital on Systemic Availability of Orally Administered Dicumarol in Rats Journal of Pharmaceutical Sciences. 68: 958-962. PMID 90143 DOI: 10.1002/Jps.2600680811 |
0.336 |
|
| 1979 |
Gibaldi M, McNamara PJ. Steady-state concentrations of drugs with short half-lives when administered in oral sustained release formulations International Journal of Pharmaceutics. 2: 167-172. DOI: 10.1016/0378-5173(79)90017-6 |
0.383 |
|
| 1978 |
McLean AJ, McNamara PJ, duSouich P, Gibaldi M, Lalka D. Food, splanchnic blood flow, and bioavailability of drugs subject to first‐pass metabolism Clinical Pharmacology & Therapeutics. 24: 5-10. PMID 657719 DOI: 10.1002/Cpt19782415 |
0.369 |
|
| 1978 |
Gibaldi M, Levy G, McNamara PJ. Effect of plasma protein and tissue binding on the biologic half-life of drugs. Clinical Pharmacology & Therapeutics. 24: 1-4. PMID 657710 DOI: 10.1002/Cpt19782411 |
0.35 |
|
| 1978 |
Lalka D, Souich Pd, McLean AJ, Gibaldi M. Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity. Journal of Pharmaceutical Sciences. 67: 591-592. PMID 641784 DOI: 10.1002/Jps.2600670449 |
0.321 |
|
| 1978 |
Colburn WA, Gibaldi M. Use of MULTDOS for Pharmacokinetic Analysis of Ethosuximide Data during Repetitive Administration of Single or Divided Daily Doses Journal of Pharmaceutical Sciences. 67: 574-575. PMID 641778 DOI: 10.1002/Jps.2600670441 |
0.32 |
|
| 1978 |
McNAMARA PJ, Colburn WA, Gibaldi M. Absorption Kinetics of Hydroflumethiazide The Journal of Clinical Pharmacology. 18: 190-193. PMID 632365 DOI: 10.1002/J.1552-4604.1978.Tb01592.X |
0.34 |
|
| 1978 |
Souich Pd, McLean AJ, Lalka D, Erill S, Gibaldi M. Pulmonary disease and drug kinetics. Clinical Pharmacokinectics. 3: 257-266. PMID 354634 DOI: 10.2165/00003088-197803040-00001 |
0.325 |
|
| 1977 |
Harrison LI, Gibaldi M. Physiologically Based Pharmacokinetic Model for Digoxin Disposition in Dogs and Its Preliminary Application to Humans Journal of Pharmaceutical Sciences. 66: 1679-1683. PMID 925929 DOI: 10.1002/Jps.2600661206 |
0.305 |
|
| 1977 |
Singhvi SM, Conway WD, Gibaldi M, Shaar S. Effect of coadministered salicylamide on terbutaline metabolism in rats Journal of Pharmaceutical Sciences. 66: 1488-1489. PMID 925911 DOI: 10.1002/Jps.2600661038 |
0.347 |
|
| 1977 |
Colburn WA, Di Santo AR, Gibaldi M. Pharmacokinetics of erythromycin on repetitive dosing Journal of Clinical Pharmacology. 17: 592-600. PMID 915023 DOI: 10.1177/009127007701701006 |
0.311 |
|
| 1977 |
Harrison LI, Gibaldi M. Physiologically Based Pharmacokinetic Model for Digoxin Distribution and Elimination in the Rat Journal of Pharmaceutical Sciences. 66: 1138-1142. PMID 894501 DOI: 10.1002/Jps.2600660822 |
0.325 |
|
| 1977 |
Colburn WA, Gibaldi M. Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration. Journal of Pharmaceutical Sciences. 66: 530-3. PMID 856973 DOI: 10.1002/Jps.2600660417 |
0.37 |
|
| 1977 |
Grundhofer B, Gibaldi M. Biopharmaceutic factors that influence effects of anticholinergic drugs: Comparison of propantheline, hexocyclium, and isopropamide Journal of Pharmaceutical Sciences. 66: 1433-1435. PMID 21951 DOI: 10.1002/Jps.2600661021 |
0.356 |
|
| 1976 |
Chremos AN, Shen D, Gibaldi M, Proctor JD, Newman JH. Time-dependent change in renal clearance of bethanidine in humans. Journal of Pharmaceutical Sciences. 65: 140-2. PMID 1255421 DOI: 10.1002/Jps.2600650136 |
0.361 |
|
| 1976 |
Colburn WA, Shen D, Gibaldi M. Pharmacokinetic analysis of drug concentration data obtained during repetitive drug administration. Journal of Pharmacokinetics and Biopharmaceutics. 4: 469-486. PMID 1011074 DOI: 10.1007/Bf01064553 |
0.348 |
|
| 1976 |
Harrison LI, Gibaldi M. Influence of cholestasis on drug elimination: Pharmacokinetics Journal of Pharmaceutical Sciences. 65: 1346-1348. PMID 966151 DOI: 10.1002/Jps.2600650921 |
0.391 |
|
| 1975 |
Gibaldi M, Perrier D. Route of Administration and Drug Disposition Drug Metabolism Reviews. 3: 185-199. PMID 4607867 DOI: 10.3109/03602537408993742 |
0.354 |
|
| 1975 |
Gibaldi M, Grundhofer B. Bioavailability of Aspirin from Commercial Suppositories Journal of Pharmaceutical Sciences. 64: 1064-1066. PMID 1133735 DOI: 10.1002/Jps.2600640649 |
0.407 |
|
| 1975 |
Gibaldi M, Axelson JE, Conway WD. Disposition of N,N-bis(phenylcarbamoylmethyl)dimethyl ammonium chloride in the rat: an interesting example of first-pass metabolism. Journal of Pharmaceutical Sciences. 64: 359-60. PMID 1127601 DOI: 10.1002/Jps.2600640245 |
0.598 |
|
| 1975 |
Shen D, Gibaldi M, Throne M, Bellward G, Cunningham R, Israili Z, Dayton P, McNay J. Pharmacokinetics of bethanidine in hypertensive patients. Clinical Pharmacology & Therapeutics. 17: 363-373. PMID 1120401 DOI: 10.1002/Cpt1975173363 |
0.323 |
|
| 1974 |
Perrier D, Gibaldi M. Drug Concentrations in the Plasma as an Index of Pharmacologic Effect The Journal of Clinical Pharmacology. 14: 415-417. PMID 4851442 DOI: 10.1002/J.1552-4604.1974.Tb02322.X |
0.328 |
|
| 1974 |
Shen D, Gibaldi M. A hypothesis for the rapid attainment and maintenance of lidocaine plasma levels Journal of Clinical Pharmacology. 14: 339-344. PMID 4845391 DOI: 10.1002/J.1552-4604.1974.Tb01409.X |
0.332 |
|
| 1974 |
Levy G, Gibaldi M. Bioavailability of Drugs Focus on Digoxin Circulation. 49: 391-394. PMID 4813169 DOI: 10.1161/01.Cir.49.3.391 |
0.354 |
|
| 1974 |
Singhvi SM, Conway WD, Gibaldi M, Boyes RN. Influence of Dose on the Metabolism and Excretion of Terbutaline in the Rat Xenobiotica. 4: 563-570. PMID 4432535 DOI: 10.3109/00498257409052097 |
0.353 |
|
| 1974 |
Axelson JE, Gibaldi M, Conway WD. Absorption, metabolism and excretion of N, N-bis(phenylcarbamoylmethyl) dimethylammonium chloride (QX-572) in the rat. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 4: 585-93. PMID 4428785 DOI: 10.1080/00498257409169761 |
0.647 |
|
| 1974 |
Shen D, Gibaldi M. Critical evaluation of use of effective protein fractions in developing pharmacokinetic models for drug distribution Journal of Pharmaceutical Sciences. 63: 1698-1703. PMID 4372337 DOI: 10.1002/Jps.2600631106 |
0.304 |
|
| 1973 |
Conway WD, Singhvi SM, Gibaldi M, Boyes RN. The Effect of Route of Administration on the Metabolic Fate of Terbutaline in the Rat Xenobiotica. 3: 813-821. PMID 4786682 DOI: 10.3109/00498257309151605 |
0.378 |
|
| 1973 |
Perrier D, Gibaldi M. Animal Models for Investigating Intestinal Drug Absorption: Various Antibiotics Journal of Pharmaceutical Sciences. 62: 1486-1490. PMID 4743098 DOI: 10.1002/Jps.2600620921 |
0.378 |
|
| 1973 |
Perrier D, Gibaldi M. Calculation of Absorption Rate Constants for Drugs with Incomplete Availability Journal of Pharmaceutical Sciences. 62: 225-228. PMID 4686394 DOI: 10.1002/Jps.2600620208 |
0.423 |
|
| 1973 |
Perrier D, Gibaldi M, Boyes RN. Prediction of systemic availability from plasma-level data after oral drug administration. Journal of Pharmacy and Pharmacology. 25: 256-257. PMID 4146327 DOI: 10.1111/J.2042-7158.1973.Tb10634.X |
0.317 |
|
| 1973 |
Perrier D, Gibaldi M. Relationship between plasma or serum drug concentration and amount of drug in the body at steady state upon multiple dosing Journal of Pharmacokinetics and Biopharmaceutics. 1: 17-22. DOI: 10.1007/Bf01060025 |
0.325 |
|
| 1972 |
Feldman S, Gibaldi M, Reinhard M. Estimation of diffusion coefficients and molecular weights of interacting colloids from dissolution-rate data. Journal of Pharmaceutical Sciences. 60: 1105-7. PMID 5115259 DOI: 10.1002/Jps.2600600728 |
0.317 |
|
| 1972 |
Gibaldi M, Grundhofer B. Drug Transport VI: Functional Integrity of the Rat Everted Small Intestine with Respect to Passive Transfer Journal of Pharmaceutical Sciences. 61: 116-119. PMID 5058626 DOI: 10.1002/Jps.2600610125 |
0.427 |
|
| 1972 |
Jusko WJ, Gibaldi M. Effects of change in elimination on varous parameters of the two-compartment open model. Journal of Pharmaceutical Sciences. 61: 1270-3. PMID 5050376 DOI: 10.1002/Jps.2600610820 |
0.314 |
|
| 1972 |
Gibaldi M, Perrier D. Drug Elimination and Apparent Volume of Distribution in Multicompartment Systems Journal of Pharmaceutical Sciences. 61: 952-954. PMID 5046120 DOI: 10.1002/Jps.2600610630 |
0.366 |
|
| 1972 |
Gibaldi M, Levy G. Dose-Dependent Decline of Pharmacologic Effects of Drugs with Linear Pharmacokinetic Characteristics Journal of Pharmaceutical Sciences. 61: 567-569. PMID 5014313 DOI: 10.1002/Jps.2600610414 |
0.382 |
|
| 1972 |
Axelson JE, Gibaldi M. Absorption and excretion of riboflavin in the rat: an unusual example of nonlinear pharmacokinetics. Journal of Pharmaceutical Sciences. 61: 404-7. PMID 5013377 DOI: 10.1002/Jps.2600610317 |
0.634 |
|
| 1972 |
Gibaldi M, Grundhofer B. Rate-limiting barriers in intestinal absorption. Experimental Biology and Medicine. 141: 564-568. PMID 4636523 DOI: 10.3181/00379727-141-36823 |
0.364 |
|
| 1972 |
Levy G, Gibaldi M, Procknal JA. Effect of an Anticholinergic Agent on Riboflavin Absorption in Man Journal of Pharmaceutical Sciences. 61: 798-799. PMID 4556316 DOI: 10.1002/Jps.2600610529 |
0.394 |
|
| 1971 |
Mayersohn M, Gibaldi M. Drug transport. IV. Influence of hypotonic and hypertonic solutions on passive drug transfer across the everted rat intestine. Journal of Pharmaceutical Sciences. 60: 326-327. PMID 5572470 DOI: 10.1002/Jps.2600600244 |
0.402 |
|
| 1971 |
Mayersohn M, Gibaldi M. Drug Transport III: Influence of Various Sugars on Passive Transfer of Several Drugs Across the Everted Rat Intestine Journal of Pharmaceutical Sciences. 60: 225-230. PMID 5572444 DOI: 10.1002/Jps.2600600214 |
0.336 |
|
| 1971 |
Gibaldi M, Levy G, Weintraub H. Commentary. Drug distribution and pharmacologic effects. Clinical Pharmacology and Therapeutics. 12: 734-42. PMID 5568257 DOI: 10.1002/Cpt1971125734 |
0.352 |
|
| 1971 |
Nightingale CH, Gibaldi M. Kinetics of drug absorption in goldfish. Journal of Pharmaceutical Sciences. 60: 1360-1363. PMID 5567584 DOI: 10.1002/Jps.2600600915 |
0.421 |
|
| 1971 |
Gibaldi M, Boyes RN, Feldman S. Influence of first‐pass effect on availability of drugs on oral administration Journal of Pharmaceutical Sciences. 60: 1338-1340. PMID 5567579 DOI: 10.1002/Jps.2600600909 |
0.375 |
|
| 1971 |
Nightingale CH, Axelson JE, Gibaldi M. Physiologic surface-active agents and drug absorption. 8. Effect of bile flow on sulfadiazine absorption in the rat. Journal of Pharmaceutical Sciences. 60: 145-7. PMID 5548230 DOI: 10.1002/Jps.2600600136 |
0.67 |
|
| 1971 |
Mayersohn M, Gibaldi M, Grundhofer B. Drug Transport V: Mechanism of Potassium‐Ion Inhibition of Passive Transfer of Solutes Across Everted Rat Intestine Journal of Pharmaceutical Sciences. 60: 1813-1817. PMID 5157995 DOI: 10.1002/Jps.2600601208 |
0.367 |
|
| 1971 |
Gibaldi M, Weintraub H. Some considerations as to the determination and significance of biologic half-life. Journal of Pharmaceutical Sciences. 60: 624-6. PMID 5128379 DOI: 10.1002/Jps.2600600430 |
0.345 |
|
| 1971 |
Gibaldi M. Pharmacokinetic Aspects Of Drug Metabolism Annals of the New York Academy of Sciences. 179: 19-31. PMID 4936775 DOI: 10.1111/J.1749-6632.1971.Tb46888.X |
0.328 |
|
| 1970 |
Weintraub H, Gibaldi M. Rotating-flask method for dissolution-rate determinations of aspirin from various dosage forms. Journal of Pharmaceutical Sciences. 59: 1792-6. PMID 5499714 DOI: 10.1002/Jps.2600591218 |
0.368 |
|
| 1970 |
Gibaldi M, Weintraub H. Quantitative correlation of absorption and in vitro dissolution kinetics of aspirin from several dosage forms. Journal of Pharmaceutical Sciences. 59: 725-6. PMID 5446442 DOI: 10.1002/Jps.2600590541 |
0.32 |
|
| 1970 |
Feldman S, Salvino M, Gibaldi M. Physiologic Surface- Active Agents and Drug Absorption VII:Effect of Sodium Deoxycholate on Phenol RedAbsorption in the Rat Journal of Pharmaceutical Sciences. 59: 705-707. PMID 5446433 DOI: 10.1002/Jps.2600590529 |
0.402 |
|
| 1970 |
Mayersohn M, Gibaldi M. Drug transport: II. The effect of various cations on the passive transfer of drugs across the everted rat intestine Biochimica Et Biophysica Acta. 196: 296-304. PMID 5414307 DOI: 10.1016/0005-2736(70)90017-9 |
0.338 |
|
| 1969 |
Nightingale CH, Gibaldi M. Bile flow in the rat after enteral administration of bile salts. Digestive Diseases and Sciences. 14: 545-556. PMID 5805230 DOI: 10.1007/Bf02232929 |
0.362 |
|
| 1969 |
Feldman S, Gibaldi M. Physiologic Surface-Active Agents and Drug Absorption I: Effect of Sodium Taurodeoxycholate on Salicylate Transfer Across the Everted Rat Intestine Journal of Pharmaceutical Sciences. 58: 425-428. PMID 5787439 DOI: 10.1002/Jps.2600580407 |
0.398 |
|
| 1969 |
Levy G, Gibaldi M, Jusko WJ. Multicompartment pharmacokinetic models and pharmacologic effects. Journal of Pharmaceutical Sciences. 58: 422-4. PMID 5787438 DOI: 10.1002/Jps.2600580406 |
0.401 |
|
| 1969 |
Gibaldi M. Effect of Mode of Administration on Drug Distribution in a Two-Compartment Open System Journal of Pharmaceutical Sciences. 58: 327-331. PMID 5782025 DOI: 10.1002/Jps.2600580308 |
0.364 |
|
| 1969 |
Gibaldi M, Feldman S, Weiner ND. Dissolution kinetics in micellar solutions under nonsink conditions. Journal of Pharmaceutical Sciences. 58: 132-3. PMID 5765824 DOI: 10.1002/Jps.2600580133 |
0.45 |
|
| 1969 |
Nightingale CH, Wynn RJ, Gibaldi M. Physiologic Surface-Active Agents and Drug Absorption III: Effect of Bile Salt on Drug Absorption in Goldfish Journal of Pharmaceutical Sciences. 58: 1005-1007. PMID 5388036 DOI: 10.1002/Jps.2600580823 |
0.388 |
|
| 1969 |
Feldman S, Gibaldi M. Bile Salt-Induced Permeability Changes in the Isolated Rat Intestine Experimental Biology and Medicine. 132: 1031-1033. PMID 5360975 DOI: 10.3181/00379727-132-34360 |
0.319 |
|
| 1969 |
Mayersohn M, Gibaldi M. Drug Transport. I. Effect of potassium ion on the in vitro transfer of several drugs across the rat intestine: preliminary observations. Journal of Pharmaceutical Sciences. 58: 1429-1430. PMID 5349771 DOI: 10.1002/Jps.2600581136 |
0.361 |
|
| 1969 |
Gibaldi M. Estimation of the pharmacokinetic parameters of the two-compartment open model from post-infusion plasma concentration data Journal of Pharmaceutical Sciences. 58: 1133-1135. PMID 5346080 DOI: 10.1002/Jps.2600580921 |
0.382 |
|
| 1969 |
Feldman S, Gibaldi M. Physiologic Surface-Active Agents and Drug Absorption II: Comparison of the Effect of Sodium Taurodeoxycholate and Ethylenediaminetetraacetic Acid on Salicylamide and Salicylate Transfer Across the Everted Rat Small Intestine Journal of Pharmaceutical Sciences. 58: 967-970. PMID 4981120 DOI: 10.1002/Jps.2600580813 |
0.374 |
|
| 1969 |
Weintraub H, Gibaldi M. Physiologic surface-active agents and drug absorption. IV. Effect of pre-micellar concentrations of surfactant on dissolution rate. Journal of Pharmaceutical Sciences. 58: 1368-72. PMID 4900222 DOI: 10.1002/Jps.2600581115 |
0.472 |
|
| 1969 |
Mayersohn M, Feldman S, Gibaldi M. Bile salt enhancement of riboflavin and flavin mononucleotide absorption in man. Journal of Nutrition. 98: 288-296. PMID 4894307 DOI: 10.1093/Jn/98.3.288 |
0.395 |
|
| 1969 |
Gibaldi M, Nagashima R, Levy G. Relationship Between Drug Concentration in Plasma or Serum and Amount of Drug in the Body Journal of Pharmaceutical Sciences. 58: 193-197. DOI: 10.1002/Jps.2600580210 |
0.354 |
|
| 1968 |
Gibaldi M, Nightingale CH. Bile salt potentiation of pharmacologic effects and drug uptake in goldfish Journal of Pharmaceutical Sciences. 57: 1354-1357. PMID 5677339 DOI: 10.1002/Jps.2600570816 |
0.375 |
|
| 1968 |
Gibaldi M, Feldman S, Weiner ND. Apparent nonsteady-state dissolution phenomenon in solutions of colloidal solubilizers. Journal of Pharmaceutical Sciences. 57: 1072-3. PMID 5671336 DOI: 10.1002/Jps.2600570647 |
0.322 |
|
| 1968 |
Gibaldi M, Weintraub H. Dissolution of salicylic acid and polyvinylpyrrolidone from compressed mixtures. Journal of Pharmaceutical Sciences. 57: 832-5. PMID 5657545 DOI: 10.1002/Jps.2600570524 |
0.385 |
|
| 1968 |
Gibaldi M, Feldman S, Wynn R, Weiner ND. Dissolution rates in surfactant solutions under stirred and static conditions. Journal of Pharmaceutical Sciences. 57: 787-91. PMID 5657535 DOI: 10.1002/Jps.2600570513 |
0.413 |
|
| 1968 |
Gibaldi M, Feldman S, Bates TR. Correlation of Pharmacologie Activity and Dissolution Rates of Reserpine-Desoxycholic Acid Dispersions Journal of Pharmaceutical Sciences. 57: 708-709. PMID 5652171 DOI: 10.1002/Jps.2600570441 |
0.316 |
|
| 1968 |
Gibaldi M, Nightingale CH. Use of the Overturn End Point for the Estimation of Absorption and Elimination Kinetics in Goldfish Journal of Pharmaceutical Sciences. 57: 226-231. PMID 5641662 DOI: 10.1002/Jps.2600570203 |
0.319 |
|
| 1968 |
Feldman S, Gibaldi M. Effect of bile salts on gastric emptying and intestinal transit in the rat. Gastroenterology. 54: 918-921. DOI: 10.1016/S0016-5085(68)80165-9 |
0.35 |
|
| 1967 |
Bates TR, Lin SL, Gibaldi M. Solubilization and rate of dissolution of drugs in the presence of physiologic concentrations of lysolecithin Journal of Pharmaceutical Sciences. 56: 1492-1495. PMID 6060594 DOI: 10.1002/Jps.2600561123 |
0.472 |
|
| 1967 |
Gibaldi M, Feldman S. Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms Journal of Pharmaceutical Sciences. 56: 1238-1242. PMID 6059440 DOI: 10.1002/Jps.2600561005 |
0.395 |
|
| 1967 |
Gibaldi M, Mufson D. Neutralization of Aluminum Hydroxide Dried Gel: Citrate and Tartrate Inhibition Journal of Pharmaceutical Sciences. 56: 46-50. PMID 6030493 DOI: 10.1002/Jps.2600560109 |
0.345 |
|
| 1967 |
Shanker J, Gibaldi M, Kanig JL, Parker AP, Lachman L. Evaluation of the suitability of butadiene-acrylonitrile rubbers as closures for parenteral solutions. Journal of Pharmaceutical Sciences. 56: 100-8. PMID 6030479 DOI: 10.1002/Jps.2600560121 |
0.709 |
|
| 1967 |
Feldman S, Gibaldi M. Effect of Urea on Solubility: Role of Water Structure Journal of Pharmaceutical Sciences. 56: 370-375. DOI: 10.1002/Jps.2600560313 |
0.34 |
|
| 1966 |
Mayersohn M, Gibaldi M. New method of solid-state dispersion for increasing dissolution rates Journal of Pharmaceutical Sciences. 55: 1323-1324. PMID 5969799 DOI: 10.1002/Jps.2600551138 |
0.313 |
|
| 1966 |
Bates TR, Gibaldi M, Kanig JL. Rate of dissolution of griseofulvin and hexoestrol in bile salt solutions. Nature. 210: 1331-3. PMID 5963762 DOI: 10.1038/2101331A0 |
0.731 |
|
| 1966 |
Goldberg AH, Gibaldi M, Kanig JL, Mayersohn M. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. IV. Chloramphenicol--urea system. Journal of Pharmaceutical Sciences. 55: 581-3. PMID 5924122 DOI: 10.1002/Jps.2600550610 |
0.753 |
|
| 1966 |
Bates TR, Gibaldi M, Kanig JL. Solubilizing properties of bile salt solutions. I. Effect of temperature and bile salt concentration on solubilization of glutethimide, griseofulvin, and hexestrol. Journal of Pharmaceutical Sciences. 55: 191-9. PMID 5923268 DOI: 10.1002/Jps.2600550213 |
0.724 |
|
| 1966 |
Bates TR, Gibaldi M, Kanig JL. Solubilizing properties of bile salt solutions. II. Effect of inorganic electrolyte, lipids, and a mixed bile salt system on solubilization of glutethimide, griseofulvin, and hexestrol. Journal of Pharmaceutical Sciences. 55: 901-6. PMID 5918525 DOI: 10.1002/Jps.2600550906 |
0.736 |
|
| 1966 |
Goldberg AH, Gibaldi M, Kanig JL. Increasing Dissolution Rates and Gastrointestinal Absorption of Drugs via Solid Solutions and Eutectic mixtures III: Experimental Evaluation of Griseofulvin—succinic Acid Solid Solution Journal of Pharmaceutical Sciences. 55: 487-492. DOI: 10.1002/Jps.2600550508 |
0.743 |
|
| 1966 |
Goldberg AH, Gibaldi M, Kanig JL. Increasing Dissolution Rates and Gastrointestinal Absorption of Drugs via solid Solutions and Eutectic mixtures II: Experimental Evaluation of a Eutectic Mixture: Urea-acetaminophen System Journal of Pharmaceutical Sciences. 55: 482-487. DOI: 10.1002/Jps.2600550507 |
0.751 |
|
| 1965 |
Goldberg AH, Gibaldi M, Kanig JL. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature. Journal of Pharmaceutical Sciences. 54: 1145-8. PMID 5882218 DOI: 10.1002/Jps.2600540810 |
0.749 |
|
| 1965 |
Gibaldi M, Kanig JL. Effect of glucosamine on urinary excretion of salicylate. Journal of Pharmaceutical Sciences. 54: 599-602. PMID 5842349 DOI: 10.1002/Jps.2600540424 |
0.741 |
|
| 1965 |
Goldberg AH, Gibaldi M, Kanig JL, Shanker J. Method for Determining Dissolution Rates of Multiparticulate Systems Journal of Pharmaceutical Sciences. 54: 1722-1725. DOI: 10.1002/Jps.2600541205 |
0.693 |
|
| 1964 |
GIBALDI M, KANIG JL, ESPIRITU P. SELECTION OF AN OPTIMAL SURFACE FOR THE PREPARATION OF UNIFORM DETACHED FILMS OF ADHESIVE MATERIALS. Journal of Pharmaceutical Sciences. 53: 1434. PMID 14253622 DOI: 10.1002/Jps.2600531145 |
0.65 |
|
| 1964 |
GIBALDI M, KANIG JL, AMSEL L. CRITICAL IN VITRO FACTORS IN EVALUATION OF GASTRIC ANTACIDS. II. INHIBITION OF NEUTRALIZATION RATE OF DRIED ALUMINUM HYDROXIDE GEL. Journal of Pharmaceutical Sciences. 53: 1375-7. PMID 14253599 DOI: 10.1002/Jps.2600531121 |
0.704 |
|
| 1964 |
ROBINSON J, GIBALDI M, WEINER ND, KANIG JL. INTERACTION OF LOW MOLECULAR WEIGHT POLYETHYLENE GLYCOLS WITH SORBITOL SOLUTION. Journal of Pharmaceutical Sciences. 53: 1245-7. PMID 14249450 DOI: 10.1002/Jps.2600531028 |
0.706 |
|
| 1963 |
DESAI S, GIBALDI M, KANIG JL. CRITICAL IN VITRO FACTORS IN EVALUATION OF GASTRIC ANTACIDS. I. POLYPEPTIDE INHIBITION. Journal of Pharmaceutical Sciences. 52: 871-7. PMID 14061048 DOI: 10.1002/Jps.2600520913 |
0.693 |
|
| 1963 |
GIBALDI M, KANIG JL. Possible error in the use of polynomial approximations in urinary excretion rate studies. Journal of Pharmaceutical Sciences. 52: 306-8. PMID 13947642 DOI: 10.1002/Jps.2600520329 |
0.687 |
|
| Show low-probability matches. |
